The National Comprehensive Cancer Network (NCCN) works to improve cancer care through their vast collection of Guidelines for Patients. The latest version of the Guidelines for Patients: Pancreatic Cancer, sponsored […]
The 2022 UCLA Activity Summary Report
The UCLA Agi Hirshberg Center for Pancreatic Diseases continues to be one of the nation’s leading institutions for pancreatic cancer research, diagnosis, and treatment thanks to funding from the Hirshberg […]
Exciting Changes to the Hirshberg Center for Pancreatic Diseases
We are seeing the seeds we planted 25 years ago with the creation of the Foundation come to full bloom. A pillar of our Foundation mission was “to create premier […]
New insights into pancreatic cancer drug resistance and metastasis
Ethan V. Abel, PhD, a 2021 Seed Grant recipient at Roswell Park Comprehensive Cancer Center, has provided an update on his research in deciphering the role of the HNF1A-SKP2 axis […]
Research Publications from the Sahin-Toth Laboratory in 2022
The most recent addition to our laboratories at UCLA, the Sahin-Toth Laboratory focuses on hereditary chronic pancreatitis, a major risk factor for pancreatic cancer. Dr. Miklos Sahin-Toth joined UCLA to […]
Research Publications from the Hirshberg Translation Laboratory in 2022
This February marks 25 years since the creation of the Ronald S. Hirshberg Translational Pancreatic Cancer Research Laboratory. A cornerstone of our research program, this lab was the first at […]